Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
@ssjoshi.bsky.social @jackiebrownmd.bsky.social
Ongoing challenge: how do we manage high risk NMIBC? Especially those with variants?
@valentinagrajales.bsky.social
And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course
@winshipatemory.bsky.social @emoryuroonc.bsky.social
And my friend @jackiebrownmd.bsky.social’s presentation on Emerging Perioperative Systemic Therapy for Urothelial Cancer at this year’s #BladderCancer course
@winshipatemory.bsky.social @emoryuroonc.bsky.social